Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — Juni 2018

Planlagt Fastgjort Låst Flyttet Genmab
2.6k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • N Offline
    N Offline
    Nickstar
    wrote on sidst redigeret af
    #587

    for mig at se handler det mere om robotter og interessen fra større fonde/investorer der styrer kursen. synes det er bekymrende at aktien ik viser styrke igennem lang tid. så håber det snart vender, for det har været en dårlig investering indtil nu

    1 Reply Last reply
    0
    • N Offline
      N Offline
      Nickstar
      wrote on sidst redigeret af
      #588

      for mig

      1 Reply Last reply
      0
      • P Offline
        P Offline
        Parasitism
        wrote on sidst redigeret af
        #589

        Vi har brug for MJ, sådan en dag som i dag 😉

        1 Reply Last reply
        0
        • E Offline
          E Offline
          E_L
          wrote on sidst redigeret af
          #590

          Evolving Treatment Strategies in Multiple Myeloma: Janssen's Darzalex Leads a Host of Novel Agents in Redefining Treatment Strategies and Approaches - https://www.prnewswire.com/news-releases/evolving-treatment-strategies-in-multiple-myeloma-janssens-darzalex-leads-a-host-of-novel-agents-in-redefining-treatment-strategies-and-approaches-300661357.html

          1 Reply Last reply
          0
          • StockBullS Offline
            StockBullS Offline
            StockBull
            wrote on sidst redigeret af
            #591

            jo ingen tvivl om det er robotter og store fonde, men på et eller andet tidspunkt må der være nogen af de store som finder genmans kurs attraktiv for en lang satsning

            1 Reply Last reply
            0
            • N Offline
              N Offline
              Nickstar
              wrote on sidst redigeret af
              #592

              ja ku man da håbe. jeg er tilgengæld meget tilfreds med køb af Ambu aktier for nogle måneder siden. den rykker! 🙂

              1 Reply Last reply
              0
              • E Offline
                E Offline
                E_L
                wrote on sidst redigeret af
                #593

                this Asian thalidomide combo started recruiting last month https://clinicaltrials.gov/ct2/history/NCT03143036?A=1&B=2&C=merged

                1 Reply Last reply
                0
                • P Offline
                  P Offline
                  Plimsoller
                  wrote on sidst redigeret af
                  #594

                  Kan ikke lige se at den her har været linket.

                  1 Reply Last reply
                  0
                  • P Offline
                    P Offline
                    Plimsoller
                    wrote on sidst redigeret af
                    #595

                    https://play.borsen.dk/klip/5b1814e945628ff8172250bc

                    1 Reply Last reply
                    0
                    • O Offline
                      O Offline
                      OHW
                      wrote on sidst redigeret af
                      #596

                      Liger et luk under 970, som nogen nok vil syntes godt om...(shortere)

                      1 Reply Last reply
                      0
                      • E Offline
                        E Offline
                        E_L
                        wrote on sidst redigeret af
                        #597

                        @Plimsoller could you summarise in 1 sentence you think?

                        1 Reply Last reply
                        0
                        • P Offline
                          P Offline
                          Plimsoller
                          wrote on sidst redigeret af
                          #598

                          Firstly they are speaking about a breakthrough in lung cancer treat
                          ment, but that is not Genmab related.

                          1 Reply Last reply
                          0
                          • P Offline
                            P Offline
                            Plimsoller
                            wrote on sidst redigeret af
                            #599

                            Second they are speaking about the CAR-T results presented at ASCO. As we know they hopefully/expected 15-18 months progression free, but the result was around 12.

                            1 Reply Last reply
                            0
                            • P Offline
                              P Offline
                              Plimsoller
                              wrote on sidst redigeret af
                              #600

                              The expert said that CAR-T is not to be considered to be a competitor to Darzalex. This due to cost and treatment “mode”. 3-4 weeks in the hospital etc.

                              1 Reply Last reply
                              0
                              • E Offline
                                E Offline
                                E_L
                                wrote on sidst redigeret af
                                #601

                                tak 😉

                                1 Reply Last reply
                                0
                                • E Offline
                                  E Offline
                                  E_L
                                  wrote on sidst redigeret af
                                  #602

                                  Subcutaneous daratumumab show benefit in patients with relapsed or refractory multiple myeloma https://www.youtube.com/watch?v=16TrK-zfVms

                                  1 Reply Last reply
                                  0
                                  • P Offline
                                    P Offline
                                    Plimsoller
                                    wrote on sidst redigeret af
                                    #603

                                    Lastet they touches upon who the focus lies on during these types of conferences - JNJ or Genmab. It is clearly on JNJ, but this year Genmab was for the first time represented physically (a booth or something I imagine), and the interpretation is that they therefore have a lot of faith in their pipeline.

                                    1 Reply Last reply
                                    0
                                    • StockBullS Offline
                                      StockBullS Offline
                                      StockBull
                                      wrote on sidst redigeret af
                                      #604

                                      Plimsoller. So to get this right. The patients died after 12 month or ?

                                      1 Reply Last reply
                                      0
                                      • P Offline
                                        P Offline
                                        Plimsoller
                                        wrote on sidst redigeret af
                                        #605

                                        Lastet = lastly. Sorry - I am on the phone.

                                        1 Reply Last reply
                                        0
                                        • P Offline
                                          P Offline
                                          Plimsoller
                                          wrote on sidst redigeret af
                                          #606

                                          They said that Bluebird presented results which showet 12 months progression free, where the analysis were hoping for 15-18 months.

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger